baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

L&S Knock-Out ATO/ DE000LX4DHZ5 /

2024-11-12 8:46:04 AM	Chg.-	Bid-	Ask-	Underlying	Strike price	Expiration date	Option type
0.100EUR	-	- Bid Size: -	- Ask Size: -	Atos SE	0.2493 EUR	2078-12-31	Call

GlobeNewswire 08-28 Atossa Therapeutics Granted Additional Patent Protection for Endoxifen

GlobeNewswire 08-21 Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Co...

GlobeNewswire 08-20 Atossa Therapeutics Announces the Appointment of Michael Parks as Vice President, Investor and Publi...

GlobeNewswire 08-14 Stevie® Awards Announce Winners in The 21st Annual International Business Awards® from Across the Gl...

GlobeNewswire 08-12 Atossa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 07-30 HUMAN Releases The Quadrillion Report: 2024 Cyberthreat Benchmarks, Uncovers Nearly 150 Million Comp...

GlobeNewswire 07-22 Atossa Therapeutics Completes Enrollment of 80mg Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE...

GlobeNewswire 07-02 Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer

GlobeNewswire 06-28 Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combin...

GlobeNewswire 06-17 Atossa Set to Join Russell 3000® Index Effective June 28, 2024

GlobeNewswire 06-11 Pythian Welcomes Brooks Borcherding as Chief Executive Officer

GlobeNewswire 06-05 Atossa to Present at the Sidoti Small-Cap Investor Conference

GlobeNewswire 05-30 Groundbreaking Technology Solves Major Problem of User Lockouts During MFA Resets

GlobeNewswire 05-28 NetLogistik Wins Partner Leadership Award from Blue Yonder

GlobeNewswire 05-28 Atossa Therapeutics Announces Support of Clinical Study Testing New, Artificial Intelligence, Breast...

GlobeNewswire 05-16 Nametag Enlisted by Newfold Digital in the Fight Against Fraud and Cybersecurity Threats

GlobeNewswire 05-15 Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Tria...

GlobeNewswire 05-15 Calian Reports Record Results for the Second Quarter

GlobeNewswire 05-13 Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 05-13 NVIDIA Grace Hopper Ignites New Era of AI Supercomputing

GlobeNewswire 05-07 Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines

GlobeNewswire 04-29 Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Eva...

GlobeNewswire 04-15 Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endo...

GlobeNewswire 04-11 Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference

L&S Knock-Out ATO/ DE000LX4DHZ5 /

If you wish to receive reply to your feedback, please provide your email address.